Noise amidst the silence: Off-target effects of siRNAs?

Rosetta Inpharmatics LLC, 401 Terry Avenue N., Seattle, WA 98109, USA.
Trends in Genetics (Impact Factor: 9.92). 12/2004; 20(11):521-4. DOI: 10.1016/j.tig.2004.08.006
Source: PubMed


RNA interference (RNAi), mediated by short interfering RNAs (siRNAs), is widely used to silence gene expression and to define gene function in mammalian cells. Initially, this gene silencing via transcript degradation was believed to be exquisitely specific, requiring near-identity between the siRNA and the target mRNA. However, several recent reports have suggested that non-specific effects can be induced by siRNAs, both at the level of mRNA and protein. These findings suggest that siRNAs can regulate the expression of unintended targets, and argue for further experiments on the mechanism and extent of off-target gene regulation(s). In the meantime, caution is warranted in interpreting gene function and phenotypes resulting from RNAi experiments.

Full-text preview

Available from:
  • Source
    • "In a parallel domain, high-throughput genome-wide screening experiments continue to provide critical insight into biology and medicine, shedding light on traditional cellular phenotypes, disease networks, and for reverse engineering endogenous pathways. Unfortunately, currently available methods are highly constrained, expensive, and often suffer from non-specific target effects1112131415. Traditionally, these assays involve mutations or RNAi and explore the effect of loss of function coupled with selective pressure151617. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The ability to perturb individual genes in genome-wide experiments has been instrumental in unraveling cellular and disease properties. Here we introduce, describe the assembly, and demonstrate the use of comprehensive and versatile transcription activator-like effector (TALE) libraries. As a proof of principle, we built an 11-mer library that covers all possible combinations of the nucleotides that determine the TALE-DNA binding specificity. We demonstrate the versatility of the methodology by constructing a constraint library, customized to bind to a known p53 motif. To verify the functionality in assays, we applied the 11-mer library in yeast-one-hybrid screens to discover TALEs that activate human SCN9A and miR-34b respectively. Additionally, we performed a genome-wide screen using the complete 11-mer library to confirm known genes that confer cycloheximide resistance in yeast. Considering the highly modular nature of TALEs and the versatility and ease of constructing these libraries we envision broad implications for high-throughput genomic assays.
    Scientific Reports 11/2014; 4:4857. DOI:10.1038/srep04857 · 5.58 Impact Factor
  • Source
    • "One of the largest hurdles in RNAi-based therapy is toxicity. In this context, independent off-target or nonspecific effects of siRNA are a concern [23, 24]. Side effects can result from unintended interactions between an siRNA compound and an unrelated host gene. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) etiological studies suggest that an elevation in amyloid-β peptides (Aβ) level contributes to aggregations of the peptide and subsequent development of the disease. The major constituent of these amyloid peptides is the 1 to 40-42 residue peptide (Aβ(40-42)) derived from amyloid protein precursor (APP). Most likely, reducing Aβ levels in the brain may block both its aggregation and neurotoxicity and would be beneficial for patients with AD. Among the several possible ways to lower Aβ accumulation in the cells, we have selectively chosen to target the primary step in the Aβ cascade, namely, to reduce APP gene expression. Toward this end, we engineered specific SOFA-HDV ribozymes, a new generation of catalytic RNA tools, to decrease APP mRNA levels. Additionally, we demonstrated that APP-ribozymes are effective at decreasing APP mRNA and protein levels as well as Aβ levels in neuronal cells. Our results could lay the groundwork for a new protective treatment for AD.
    International Journal of Alzheimer's Disease 02/2012; 2012:947147. DOI:10.1155/2012/947147
  • Source
    • "We were concerned that the silencing of Cm-eIF4E could also result in the indirect silencing of Cm-eIF(iso)4E because these two genes share 75% of their nucleotide sequences. Nonspecific silencing, which is based on partial sequence homology, has been described previously (Jackson and Linsley, 2004; Scacheri et al., 2004). Recently, it has been shown that the silencing of HC-Pro from ZYMV in cucumber and melon resulted in resistance to ZYMV, but also to PRSV and WMV (Leibman et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Efficient and sustainable control of plant viruses may be achieved using genetically resistant crop varieties, although resistance genes are not always available for each pathogen; in this regard, the identification of new genes that are able to confer broad-spectrum and durable resistance is highly desirable. Recently, the cloning and characterization of recessive resistance genes from different plant species has pointed towards eukaryotic translation initiation factors (eIF) of the 4E family as factors required for the multiplication of many different viruses. Thus, we hypothesized that eIF4E may control the susceptibility of melon (Cucumis melo L.) to a broad range of viruses. To test this hypothesis, Cm-eIF4E knockdown melon plants were generated by the transformation of explants with a construct that was designed to induce the silencing of this gene, and the plants from T2 generations were genetically and phenotypically characterized. In transformed plants, Cm-eIF4E was specifically silenced, as identified by the decreased accumulation of Cm-eIF4E mRNA and the appearance of small interfering RNAs derived from the transgene, whereas the Cm-eIF(iso)4E mRNA levels remained unaffected. We challenged these transgenic melon plants with eight agronomically important melon-infecting viruses, and identified that they were resistant to Cucumber vein yellowing virus (CVYV), Melon necrotic spot virus (MNSV), Moroccan watermelon mosaic virus (MWMV) and Zucchini yellow mosaic virus (ZYMV), indicating that Cm-eIF4E controls melon susceptibility to these four viruses. Therefore, Cm-eIF4E is an efficient target for the identification of new resistance alleles able to confer broad-spectrum virus resistance in melon.
    Molecular Plant Pathology 02/2012; 13(7):755-63. DOI:10.1111/j.1364-3703.2012.00785.x · 4.72 Impact Factor
Show more